A phase II/III study of JZP-458 in patients with acute lymphoblastic leukemia (ALL)/lymphoblastic lymphoma (LBL) who are hypersensitive to E. coli-derived asparaginases.

Luke Maese,Rachel E. Rau,Elizabeth A. Raetz,Tong Lin,Pil Kim,Reddy Chandula,Sherrie McClung,Julie Gray,L. Mi Rim Choi,Mignon L. Loh,Peter C. Adamson

A phase II/III study of JZP-458 in patients with acute lymphoblastic leukemia (ALL)/lymphoblastic lymphoma (LBL) who are hypersensitive to E. coli-derived asparaginases.

2020

Luke Maese
Rachel E. Rau
Elizabeth A. Raetz
Tong Lin
Pil Kim
Reddy Chandula
Sherrie McClung
Julie Gray
L. Mi Rim Choi
Mignon L. Loh
Peter C. Adamson

TPS7568Background: L-asparaginase is an important component of ALL therapy and the inability to receive asparaginase secondary to hypersensitivity has been associated with poor patient (pt) outcome...

Keywords:

Lymphoblastic lymphoma
in patient
Lymphoblastic Leukemia
Pathology
Cancer research
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations